About: Untersuchungen zur prophylaktischen Wirkung der Verfütterung eines Probiotikums und von erregerspezifischen Kolostrum‐ und Dotterantikörpern bei neugeborenen Kälbern

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Untersuchungen zur prophylaktischen Wirkung der Verfütterung eines Probiotikums und von erregerspezifischen Kolostrum‐ und Dotterantikörpern bei neugeborenen Kälbern Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Untersuchungen zur prophylaktischen Wirkung der Verfütterung eines Probiotikums und von erregerspezifischen Kolostrum‐ und Dotterantikörpern bei neugeborenen Kälbern
Creator	Erhard, M Leuzinger, K Stangassinger, M
Source	PMC
abstract	Studies on the prophylactic effect of feeding probiotics, pathogen‐specific colostrum antibodies or egg yolk antibodies in newborn calves The prophylactic efficacy of feeding probiotics, specific egg yolk antibodies and specific colostrum antibodies on neonatal diarrhoea was investigated in a field trial with calves, grouped (n = 39/40 per group) according to the following treatments: Group I: feeding no additive; Group II: feeding probiotics (5 g powder/day with Bacillus cereus var. toyoi); Group III: feeding egg powder (10 g/day with specific egg yolk antibodies against rotavirus, coronavirus and Escherichia coli F5); Group IV: feeding colostrum antibodies (10 ml/day containing 1 g bovine immunoglobulins with specific antibodies against rotavirus, coronavirus and E. coli antigens); Group V: feeding egg powder together with probiotics (according to group II and III). The additives were given twice daily with the meal from day 2 to day 14 post‐natum. The presence of infectious agents was proved in fecal samples of all calves. Intestinal infections with rotavirus (30.8% of the calves) predominated compared to those with coronavirus (7.1%), E. coli F5 (1.5%) and cryptosporidia (24.2%). In contrast to earlier studies, the manifestation of diarrhoea did not differ significantly between the five groups. Only the growth rate of the calves between day 2 and day 14 of life as a measure of their welfare showed treatmentFspecific differences. The control group (I) showed the lowest body weight gain of about 5.8 kg (SD 5.0), whereas in the treated groups it averaged 6.3 kg (SD 4.1, p = 0,60; group II), 6.8 kg (SD 4.3, p = 0.36; group III), 6.9 kg (SD 4.7, p = 0.61; group IV) and 7.7 kg (SD 4.9, p = 0.08; group V). Considering only the rotavirus‐positive calves the body weight gain of the control group (I) was 3.5 kg (SD 4.8) and of the treated groups was 3.8 kg (SD 3.3, p = 0.65; II), 5.0 kg (SD 3.5, p = 0.54; III), 6.6 kg (SD 4.5, p = 0.05; IV) and 6.1 kg (SD 5.0, p = 0.13; V). Obviously, the feeding of antibodies from colostrum or from egg powder does increase the mean body weight gain. The feeding of probiotics alone has nearly no effect. However, in the combination with specific egg antibodies probiotics seem to have a synergistic effect. In serum from the 198 newborn calves the IgG concentration averaged 4.9 mg/ml serum (SD 3.3). From 93 dams of these calves a sample of the first colostrum could be obtained showing a mean IgG concentration of 22.0 mg/ml (SD 11.0). IgG levels in the colostrum and in the serum have been positively correlated (r = 0.37, p < 0.05). Calves with a high intensity of diarrhoea had a significantly (p = 0.01) lower mean IgG serum level (3.7 mg/ml; n = 36; SD 2.5) than calves without diarrhoea (5.6 mg/ml; n = 75; SD 4.0).
has issue date	2008-10-09(xsd:dateTime)
bibo:doi	10.1046/j.1439-0396.2000.00284.x
has license	no-cc
sha1sum (hex)	4b4adb9ec1b27049d3f1c045fe2cadde4fb09b27
schema:url	https://doi.org/10.1046/j.1439-0396.2000.00284.x
resource representing a document's title	Untersuchungen zur prophylaktischen Wirkung der Verfütterung eines Probiotikums und von erregerspezifischen Kolostrum‐ und Dotterantikörpern bei neugeborenen Kälbern
has PubMed Central identifier	PMC7166595
schema:publication	J Anim Physiol Anim Nutr (Berl)
resource representing a document's body	covid:4b4adb9ec1b27049d3f1c045fe2cadde4fb09b27#body_text
is schema:about of	named entity 'calves' named entity 'Kot' named entity 'manifestation' named entity 'Copyright Clearance Center' named entity 'egg' named entity 'powder' named entity 'combination' named entity 'calves' named entity 'Group V' named entity 'mit' named entity 'die' named entity 'Gruppen' named entity 'werden' named entity 'Statement' named entity 'Obviously' named entity 'feeding' named entity 'The' named entity 'daily' named entity 'FEEDING' named entity 'DAMS' named entity 'MG%' named entity 'DES' named entity 'THEIR' named entity 'SERUM' named entity '6.9' named entity 'GEF' named entity 'LOWER' named entity 'ZWEI' named entity '0.65' named entity 'MAL' named entity 'TREATED' named entity 'III' named entity 'BEI' named entity 'POST' named entity 'INTESTINAL INFECTIONS' named entity 'BACILLUS CEREUS' named entity 'GROWTH RATE' named entity '2C5' named entity '3.3' named entity 'GROUPED' named entity '0.36' named entity 'CONSIDERING' named entity 'NEONATAL DIARRHOEA' named entity 'EARLIER' covid:arg/4b4adb9ec1b27049d3f1c045fe2cadde4fb09b27 named entity 'day' named entity 'einem' named entity 'field trial' named entity 'diarrhoea' named entity 'calves' named entity 'specific' named entity 'rotavirus' named entity 'bovine' named entity 'var' named entity 'analog' named entity 'body weight' named entity 'den' named entity 'Dazu' named entity 'correlated' named entity 'body weight' named entity 'concentration' named entity 'mit' named entity 'colostrum' named entity 'antibodies' named entity 'IgG' named entity 'feeding' named entity 'die' named entity 'Die' named entity 'probiotics' named entity 'coronavirus' named entity 'Calves' named entity 'studies' named entity 'III' named entity 'colostrum' named entity 'gain' named entity 'Mal' named entity 'rotavirus' named entity 'probiotics' named entity 'field trial' named entity 'Bacillus cereus' named entity 'antibodies'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software